Bruker BRKR Bsi Biospin — Selling General And Administrative Expense

Other segment segments

Similar metrics at other companies

BIIBSPINRAZA — Expensereflectedwithinstatementsofincome

$71.25M+21.5%

BIIBReportable Segment — SG&A

$608.4M+1.2%

TEC

TECHDiagnostics And Spatial Biology — Selling General And Administrative Expense

$27.62M-17.4%

BBIOReportable Segment — SG&A

$163.9M+54.1%

ALife Sciences and Diagnostics Markets — Selling, General and Administrative Expense

$170M+8.3%

TEC

TECHProtein Sciences — Selling General And Administrative Expense

$57.91M+3.8%

Questions, answered.

What is Bruker's bsi biospin — selling general and administrative expense?

Bruker (BRKR) reported bsi biospin — selling general and administrative expense of $41.8M in Q1 2026.

How has Bruker's bsi biospin — selling general and administrative expense changed year-over-year?

Bruker's bsi biospin — selling general and administrative expense increased by 7.2% year-over-year, from $39M to $41.8M.

What is the long-term trend for Bruker's bsi biospin — selling general and administrative expense?

Over 3 years (2022 to 2025), Bruker's bsi biospin — selling general and administrative expense has grown at a 10.4% compound annual growth rate (CAGR), from $121M to $162.7M.

What does bsi biospin — selling general and administrative expense mean?

The overhead and operating costs required to run the BioSpin segment's business functions.

How do you interpret bsi biospin — selling general and administrative expense?

A decrease relative to revenue suggests improved operational leverage, while an increase may signal higher investment in sales or administrative bloat.

How does bsi biospin — selling general and administrative expense compare across companies?

Standard SG&A expense category found in most corporate segment disclosures.